Nation
World
Politics
Sports
Business
Entertainment
Life
Tech
Science
Opinion
Crime
Health
Oddities

GSK Plc: FDA Approves Ojjaara For Myelofibrosis Patients With Anaemia

Por: RTTNews Health September 18, 2023

thumbnail

GSK plc (,) announced the FDA has approved Ojjaara for the treatment of intermediate or high-risk myelofibrosis, including primary myelofibrosis or secondary myelofibrosis, in adults with anaemia. GSK said, to date, it is the only approved medicine for both newly diagnosed and previously treated myelofibrosis patients with anaemia that addresses the key manifestations of the disease, namely anaemia, constitutional symptoms, and splenomegaly.The... + full article



Similar News

MorphoSys To Release Myelofibrosis Trial Data This Year

RTTNews USA Health June 06, 2023

thumbnailShares of MorphoSys AG (), which have been experiencing strong momentum this year, touched a new 52-week high of $6.85 during intraday trading yesterday. This global commercial-stage biopharmaceutical company is focused on developing therapies for difficult-to-treat and... + más

2022 Associated Press All-America Team | Associated Press

Ohio State wide receiver Marvin Harrison Jr. earns spot on AP All-America team | 10 WBNS


High school scores and top performers from Tuesday, March 28

Orlando Sentinel USA Sports March 29, 2023

thumbnailLake Brantley 9, Seminole 6 (8 inn.) Buzz: Jackson Golden went 2-for-5 with 2 home runs and 6 RBI for Lake Brantley. Ben Colley had a home run. Bryce Carter had 2 hits for Seminole. Mount Dora Christian Academy 10, Oak Hall (Gainesville) 4 Buzz: Collin Priest went 5-for-5 with a... + más

NFL Playoff Scenarios | ABC News

Le Krewe du Roi celebrates the state at 58th annual Mardi Gras Ball | The Advocate


High school scores and top performers from Friday, March 24

Orlando Sentinel USA Sports March 25, 2023

thumbnailOrangewood Christian 11, The Master’s Academy 1 Buzz: Austin Waring threw 5 innings of 1-run ball (0 earned runs) while allowing 4 hits and striking out 8 for Orangewood Christian. He lowered his season ERA to 0.78. Aiden McKee went 3-for-3 with a double, a walk, an RBI and a... + más

NFL Playoff Scenarios | ABC News

Le Krewe du Roi celebrates the state at 58th annual Mardi Gras Ball | The Advocate


High school scores and top performers from Thursday, March 9

Orlando Sentinel USA Sports March 10, 2023

thumbnailEast Ridge 10, South Lake 5 Buzz: Javier Calzadilla went 2-for-3 with a double, RBI and 3 runs scored for the Knights (7-1), while Tyler Rooks had a hit and 3 RBI and Asa Benz added a hit, run scored and 2 RBI. Ethan Stephens went 3-for-3 for the Eagles (3-4) in the loss, while... + más

NFL Playoff Scenarios | ABC News

Le Krewe du Roi celebrates the state at 58th annual Mardi Gras Ball | The Advocate


FDA Panel Backs GSK’s RSV Vaccine for Older People

Time USA Health March 03, 2023

thumbnailGSK Plc’s vaccine for won the support of a key panel of U.S. regulatory advisers for use in people aged 60 and older, as the drugmaker races against Pfizer Inc. to bring to market the first vaccine for RSV. The panel of 12 outside advisers to the Food and Drug Administration... + más

FDA advisors recommend GSK's RSV vaccine for older adults, but flag potential safety risks | CNBC

GSK vaccine for older adults granted FDA priority review | Fox Business


FDA advisors recommend GSK's RSV vaccine for older adults, but flag potential safety risks

CNBC USA Health March 01, 2023

thumbnailwatch nowVIDEO1:5501:55FDA advisory panel votes in favor of adult RSV vaccine from GSK PLCThe Food and Drug Administration's independent panel of advisors on Wednesday recommended RSV vaccine for adults ages 60 and older, though they flagged potential safety issues over... + más

FDA Panel Backs GSK’s RSV Vaccine for Older People | Time

GSK vaccine for older adults granted FDA priority review | Fox Business


GSK vaccine for older adults granted FDA priority review

Fox Business USA Business November 02, 2022

thumbnailCheck out what's clicking on FoxBusiness.com GSK opened 2% higher in U.S. trading Wednesday but closed down 2%. Shares rose after the drugmaker reported financial results that beat Wall Street forecasts and announced the Food and Drug Administration had accepted a biologics... + más

GSK Raises 2022 Guidance as 3Q Sales Beat Expectations -- Update | MarketWatch

GSK Raises 2022 Guidance as 3Q Sales Beat Expectations -- Update | MarketWatch



About iurex | Privacy Policy | Disclaimer |